Synthetic methodology utilized to prepare substituted imidazole p38 MAP kinase inhibitors
- PMID: 14758763
Synthetic methodology utilized to prepare substituted imidazole p38 MAP kinase inhibitors
Abstract
In this manuscript, we review the synthetic methods utilized to prepare a variety of imidazole p38 MAP kinase inhibitors. Several methods have been used to prepare the key templates that are discussed; manipulation of the heterocycles around the imidazole core are also considered in the context of their biological activity. Finally, we discuss new synthetic methodologies discovered in our laboratories, which are useful for the preparation of a member of this class of tetrasubstituted imidazole p38 inhibitors. The optimal route involves the thiazolium-catalyzed cross-benzoin condensation of a pyridine aldehyde with an N-acylimine. The pyridine aldehyde was prepared in three steps and 68% yield from 2-chloro-4-cyanopyridine. The tosylamide precursor to the N-acylimine was prepared in two steps and 93% yield from isonipecotic acid. We demonstrate the scope and some preliminary mechanistic studies concerning this new reaction. The resulting alpha-ketoamide is then cyclized with methyl ammonium acetate to provide the desired tetrasubstituted imidazole. Cbz deprotection and formation of a pharmaceutically acceptable salt completes the synthesis in six steps and 38% overall yield.
Similar articles
-
Identification of regioisomers in a series of N-substituted pyridin-4-yl imidazole derivatives by regiospecific synthesis, GC/MS, and 1H NMR.J Org Chem. 2003 May 30;68(11):4527-30. doi: 10.1021/jo026619w. J Org Chem. 2003. PMID: 12762762
-
Novel substituted pyridinyl imidazoles as potent anticytokine agents with low activity against hepatic cytochrome P450 enzymes.J Med Chem. 2003 Jul 17;46(15):3230-44. doi: 10.1021/jm030766k. J Med Chem. 2003. PMID: 12852754
-
Targeting the ribose and phosphate binding site of p38 mitogen-activated protein (MAP) kinase: synthesis and biological testing of 2-alkylsulfanyl-, 4(5)-aryl-, 5(4)-heteroaryl-substituted imidazoles.J Med Chem. 2008 Sep 25;51(18):5630-40. doi: 10.1021/jm800373t. J Med Chem. 2008. PMID: 18763757
-
Synthesis development of a naphthyridinone p38 kinase inhibitor.Curr Opin Drug Discov Devel. 2006 Nov;9(6):792-805. Curr Opin Drug Discov Devel. 2006. PMID: 17117687 Review.
-
P38 MAP kinase inhibitors: evolution of imidazole-based and pyrido-pyrimidin-2-one lead classes.Curr Top Med Chem. 2005;5(10):987-1003. doi: 10.2174/1568026054985876. Curr Top Med Chem. 2005. PMID: 16178742 Review.
Cited by
-
Current advances in the synthesis and biological potencies of tri- and tetra-substituted 1H-imidazoles.Mol Divers. 2015 Aug;19(3):577-623. doi: 10.1007/s11030-015-9590-6. Epub 2015 Apr 12. Mol Divers. 2015. PMID: 25863807 Review.
-
Wells-Dawson heteropolyacid supported on silica: a highly efficient catalyst for synthesis of 2,4,5-trisubstituted and 1,2,4,5-tetrasubstituted imidazoles.Mol Divers. 2010 Nov;14(4):635-41. doi: 10.1007/s11030-009-9197-x. Epub 2009 Oct 29. Mol Divers. 2010. PMID: 19866367
-
C-H bonds as ubiquitous functionality: a general approach to complex arylated imidazoles via regioselective sequential arylation of all three C-H bonds and regioselective N-alkylation enabled by SEM-group transposition.J Org Chem. 2010 Aug 6;75(15):4911-20. doi: 10.1021/jo100727j. J Org Chem. 2010. PMID: 20608749 Free PMC article.
-
Sonochemical synthesis of 1,2,4,5-tetrasubstituted imidazoles using nanocrystalline MgAl2O4 as an effective catalyst.J Adv Res. 2013 Nov;4(6):509-14. doi: 10.1016/j.jare.2012.09.001. Epub 2012 Dec 21. J Adv Res. 2013. PMID: 25685459 Free PMC article.